In ITP patients, the serum level of APRIL cannot be lowered by glucocorticoid therapy which can significantly reduce BAFF [15, 16], but may be effectively reduced by vitamin D3 [15]. The gene discussed is TNFSF13B; the disease is autoimmune thrombocytopenic purpura.